These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25401733)

  • 1. Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry.
    Gisondi P; Cazzaniga S; Chimenti S; Maccarone M; Picardo M; Girolomoni G; Naldi L;
    Br J Dermatol; 2015 Jun; 172(6):1613-1620. PubMed ID: 25401733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy.
    Gisondi P; Pezzolo E; Lo Cascio G; Girolomoni G
    Br J Dermatol; 2014 Oct; 171(4):884-90. PubMed ID: 24863903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of latent tuberculosis infection in patients with moderate to severe psoriasis taking biologic therapies in a dermatologic private practice in Miami, Florida.
    Medina-Gil C; Dehesa L; Vega A; Kerdel F
    Int J Dermatol; 2015 Jul; 54(7):846-52. PubMed ID: 26108266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry.
    Sánchez-Moya AI; García-Doval I; Carretero G; Sánchez-Carazo J; Ferrandiz C; Herrera Ceballos E; Alsina M; Ferrán M; López-Estebaranz JL; Gómez-García F; De la Cueva Dobao P; Carrascosa JM; Vanaclocha F; Belinchón I; Peral F; Dauden E;
    J Eur Acad Dermatol Venereol; 2013 Nov; 27(11):1366-74. PubMed ID: 23134268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of tuberculosis infection in psoriatic patients on anti-TNF therapy: report of a case series with 144 patients.
    Sánchez-Moya AI; Dauden E
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):730-3. PubMed ID: 21564322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the prevalence of latent tuberculosis infection in patients with moderate to severe plaque psoriasis in Spain: The Latent study.
    Ribera M; Zulaica A; Pujol C; Alonso ML; Rodriguez IM; Garcia-Calvo C;
    Actas Dermosifiliogr; 2015 Dec; 106(10):823-9. PubMed ID: 26381434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates of latent tuberculosis infection in patients treated with TNF inhibitors for psoriasis: a retrospective chart review.
    Lee EB; Amin M; Man J; Egeberg A; Wu JJ
    J Dermatolog Treat; 2018 Nov; 29(7):671-675. PubMed ID: 29455561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of latent tuberculosis infection in autoimmune disorders such as psoriasis and in chronic respiratory diseases, including lung cancer.
    Bordignon V; Bultrini S; Prignano G; Sperduti I; Piperno G; Bonifati C; Filippetti M; Toma L; Latini A; Di Cecio M; Giuliani A; Vocaturo A; Trento E; D' Agosto G; Francesconi F; Cataldo A; Vento A; Cilenti V; Berardesca E; Ameglio F; Cordiali Fei P; Ensoli F
    J Biol Regul Homeost Agents; 2011; 25(2):213-20. PubMed ID: 21880210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired latent tuberculosis infection in psoriasis patients treated with etanercept in the People's Republic of China.
    Li CR; Mao QX; Chen M; Jia WX; Yao X; Feng SY; Jia H; Gong JQ; Yang XY
    Drug Des Devel Ther; 2015; 9():5591-4. PubMed ID: 26508833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis.
    Sauzullo I; Mengoni F; Marocco R; Potenza C; Skroza N; Tieghi T; Lichtner M; Vullo V; Mastroianni CM
    Br J Dermatol; 2013 Nov; 169(5):1133-40. PubMed ID: 23909256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with psoriasis are more likely to be treated for latent tuberculosis infection prior to biologics than patients with inflammatory bowel disease.
    Bassukas ID; Kosmidou M; Gaitanis G; Tsiouri G; Tsianos E
    Acta Derm Venereol; 2011 Jun; 91(4):444-6. PubMed ID: 21547342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Latent Tuberculosis in the Patient With Moderate to Severe Psoriasis Who Is a Candidate for Systemic and/or Biologic Therapy.
    Martínez-López A; Rodriguez-Granger J; Ruiz-Villaverde R
    Actas Dermosifiliogr; 2016 Apr; 107(3):207-14. PubMed ID: 26651325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study.
    Torres T; Chiricozzi A; Puig L; Lé AM; Marzano AV; Dapavo P; Dauden E; Carrascosa JM; Lazaridou E; Duarte G; Carvalho AVE; Romiti R; Rompoti N; Teixeira L; Abreu M; Ippoliti E; Maronese CA; Llamas-Velasco M; Vilarrasa E; Del Alcázar E; Daponte AI; Papoutsaki M; Carugno A; Bellinato F; Gisondi P
    Am J Clin Dermatol; 2024 Mar; 25(2):333-342. PubMed ID: 38265746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should all patients undergoing treatment with biologic agents be screened annually for latent tuberculosis infection with an interferon gamma release assay?
    Johnson MG; Bialas RW; Hall RP; Stout JE
    J Dermatolog Treat; 2016 Aug; 27(4):378-80. PubMed ID: 26652171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection.
    Tsai TF; Ho V; Song M; Szapary P; Kato T; Wasfi Y; Li S; Shen YK; Leonardi C;
    Br J Dermatol; 2012 Nov; 167(5):1145-52. PubMed ID: 22803615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of latent tuberculosis infection and associated risk factors in an urban African setting.
    Kizza FN; List J; Nkwata AK; Okwera A; Ezeamama AE; Whalen CC; Sekandi JN
    BMC Infect Dis; 2015 Mar; 15():165. PubMed ID: 25879423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis Screening in Patients with Psoriasis Receiving Biologic Therapy: A Retrospective Cohort Study.
    Snast I; Bercovici E; Avni T; Shitenberg D; Hodak E; Pavlovsky L
    Acta Derm Venereol; 2018 Nov; 98(10):979-980. PubMed ID: 30085327
    [No Abstract]   [Full Text] [Related]  

  • 19. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test.
    Laffitte E; Janssens JP; Roux-Lombard P; Thielen AM; Barde C; Marazza G; Panizzon RG; Saurat JH
    Br J Dermatol; 2009 Oct; 161(4):797-800. PubMed ID: 19659473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inequalities in access to biological treatments for psoriasis: results from the Italian Psocare registry.
    Naldi L; Cazzaniga S; Di Mercurio M; Grossi E; Addis A;
    Br J Dermatol; 2017 May; 176(5):1331-1338. PubMed ID: 27973689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.